Home » Topics » Regulatory » Patents

Patents
RSS

Fujisawa reports heterocyclic glutamate receptor antagonists

Nov. 11, 1997

PPAR-gamma agonists for endocrine and metabolic disorders

Nov. 11, 1997

Neurogen describes dopamine receptor subtype-specific ligands

Nov. 11, 1997

New oxazolidinone antibiotics described by Zeneca

Nov. 11, 1997

New taxoids from RPR

Nov. 10, 1997

Inhibitors of ECE prepared at Roussel Uclaf/INSERM

Nov. 10, 1997

Novartis reports protein tyrosine kinase inhibitors for bone disorders

Nov. 10, 1997

Quinoxalinediones for neurodegenerative/neurological disorders patented

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Takeda describes new melatonin agonists

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...